Sitagliptin improves plasma apolipoprotein profile in type 2 diabetes : A randomized clinical trial of sitagliptin effect on lipid and glucose metabolism (SLIM) study
AIM: This study aims to evaluate the effect of dipeptidyl peptidase-4 inhibitors on lipid metabolism in patients with type 2 diabetes mellitus (T2D).METHODS: This is a multicenter, open-labeled, randomized controlled study. T2D patients with HbA1c 6.9-8.9% (52-74 mmol/mol) who were under treatment with sulfonylurea were randomly allocated to either the sitagliptin group or the non-sitagliptin grou